Results 161 to 170 of about 672,318 (344)

Premorbid Personality Characteristics in Alzheimer’s Disease: An Exploratory Case–Control Study [PDF]

, 1997
Michael Malinchoc, W. A. Rocca, Robert C. Colligan, K. P. Offord, E. Kokmen   +4 more
openalex   +1 more source

PND61 LITERATURE REVIEW ON THE POTENTIAL SOCIETAL IMPACT OF DISEASE-MODIFYING THERAPIES IN ALZHEIMER€™S DISEASE [PDF]

Value in Health, 2019
T. Mantopoulos, T. Dort, G. Spentzouris, C. Quinn, R. Thompson, H. Wieffer   +5 more
openaire   +2 more sources

Additional file 1: of Role of transient receptor potential ankyrin 1 channels in Alzheimerâ s disease

, 2016
Supplementary figures. (PDF 547Â kb)
Kuan-I Lee, Hsueh-Te Lee, Hui-Ching Lin, Huey-Jen Tsay, Tsai, Feng-Chuan, Song-Kun Shyue, Tzong-Shyuan Lee   +6 more
openaire   +1 more source

Photothermal Hydrogel with Mn3O4 Nanoparticles Alleviates Intervertebral Disc Degeneration by Scavenging ROS and Regulating Extracellular Matrix Metabolism

Advanced Functional Materials, EarlyView.
The MPTT‐nanozyme‐hydrogel system (Mn3O4@ChS‐HA) provides a multifunctional therapeutic strategy for intervertebral disc degeneration (IVDD), effectively targeting oxidative stress and enhancing AF repair by restoring extracellular matrix (ECM) and redox homeostasis.
Yangyang Chen, Chan Xue, Feifei Ni, Binwu Hu, Miaoheng Yan, He Zhang, Yuxiang Hu, Xiaoyao Peng, Guangfang Li, Yu Han, Hongjian Liu, Zengwu Shao, Qin Wang, Yulong Wei   +13 more
wiley   +1 more source

Contingent Vulnerability of Entorhinal Parvalbumin-Containing Neurons in Alzheimer’s Disease [PDF]

, 1996
Ana Solodkin, Stacy D. Veldhuizen, Gary W. Van Hoesen   +2 more
openalex   +1 more source

PND64 TRENDS AND DISPARITIES IN PHARMACEUTICAL TREATMENT FOR ALZHEIMER’S DISEASE AND RELATED DEMENTIA PATIENTS [PDF]

Value in Health, 2019
Emmanuel F Drabo, Patricia Ferido, Geoffrey F. Joyce, Julie Zissimopoulos, Douglas Barthold   +4 more
openaire   +2 more sources

MOESM1 of Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype

, 2019
Additional file 1: Table S1. Systematic literature search for AD proteomics studies.
Hesse, Raphael, Maica Hurtado, Jackson, Rosemary, Eaton, Samantha, Herrmann, Abigail, Colom-Cadena, Marti, Makis Tzioras, King, Declan, Rose, Jamie, Tulloch, Jane, Chris-Anne McKenzie, Smith, Colin, Henstridge, Christopher, Lamont, Douglas, Wishart, Thomas, Spires-Jones, Tara   +15 more
openaire   +1 more source

Engineering a Single Amino Acid Bionanozyme for Ultrasensitive Detection of Biomarkers: A WHO‐REASSURE‐ Aligned Approach

Advanced Functional Materials, EarlyView.
A unique 2D bionanozyme, engineered from a single amino acid and copper ions, demonstrates peroxidase‐mimicking catalytic activity. This efficient and simple bionanozyme allows for ultrasensitive, equipment‐free visual detection of key biomarkers in both test and real samples, meeting the WHO‐REASSURE standards for practical diagnostic applications ...
Subrat Vishwakarma, Om Shanker Tiwari, Vijay Kumar Patel, Ruchi Shukla, Ehud Gazit, Pandeeswar Makam   +5 more
wiley   +1 more source

Processing of Wild‐Type and Mutant Familial Alzheimer’s Disease‐Associated Presenilin‐1 in Cultured Neurons [PDF]

, 1999
Conrad C. Weihl, Ghanaysham D. Ghadge, Richard Miller, Raymond P. Roos   +3 more
openalex   +1 more source

Additional file 4: of Older patients are still under-represented in clinical trials of Alzheimerâ s disease

, 2016
Main characteristics of trials included in the age analyses (79). (DOCX 30 kb)
Banzi, Rita, Camaioni, Paolo, Tettamanti, Mauro, Bertele’, Vittorio, Lucca, Ugo   +4 more
openaire   +1 more source